Callan Family Office’s Synovus SNV Stock Holding History

Callan Family Office’s Portfolio SNV Stock Details SNV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-32,377	Closed	-$1.62M	–	1173
2025 Q4	$1.62M	Buy	32,377 +4,902	+18%	+$236K	0.03%	406
2025 Q3	$1.35M	Sell	27,475 -16	-0.1%	-$820	0.04%	330
2025 Q2	$1.42M	Buy	27,491 +3,198	+13%	+$147K	0.04%	327
2025 Q1	$1.14M	Buy	24,293 +54	+0.2%	+$2.79K	0.09%	200
2024 Q4	$1.24M	Buy	24,239 +1,616	+7%	+$83.7K	0.08%	212
2024 Q3	$1.01M	Buy	+22,623	New	+$989K	0.17%	67

Other funds holding SNV

WBWA

William B. Walkup & Associates Columbia, South Carolina $167M AUM 20.75% 1-Year Est. Return

Callan Family Office's SNV Position: Q1 2026 in Review

Callan Family Office sold out of Synovus (SNV) in Q1 2026, closing a stake of 32,377 shares — an estimated $1.62M sold.

Callan Family Office first reported a position in SNV in Q3 2024 and held it in 6 quarters. The position peaked at $1.62M in Q4 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

Callan Family Office reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
Callan Family Office sold 32,377 Synovus shares in Q1 2026, an estimated $1.62M.
Callan Family Office first reported a position in Synovus in Q3 2024 and held it in 6 quarters.
Callan Family Office's Synovus position peaked at $1.62M in Q4 2025.
1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.